3709
document
6 mai 2014 - 00h00
SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%
document
6 mai 2014 - 00h00
SCOR delivers a strong performance for the first quarter 2014 with a net income of EUR 135 million, up 21.6%
Communiqué de presse
Renouvellements du 1er avril de SCOR Global P&C.
document
30 avril 2014 - 00h00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets.
document
30 avril 2014 - 00h00
The SCOR Global P&C 1 April renewals lead to premium growth of 8.5% with expected profitability well within targets
document
30 avril 2014 - 00h00
Les renouvellements du 1er avril de SCOR Global P&C se traduisent par une croissance des primes de 8,5 %, avec une rentabilité anticipée conforme aux objectifs fixés
document
28 avril 2014 - 00h00
The pharmaceutical industry has been actively seeking the ideal treatment for hepatitis C for years: a treatment whose features would be an eradication of the virus from the body in 100% of cases.
